Angiotensin II type 1 receptor blockers as a first choice in patients with acute myocardial infarction

BACKGROUND/AIMS: Angiotensin II type 1 receptor blockers (ARBs) have not been adequately evaluated in patients without left ventricular (LV) dysfunction or heart failure after acute myocardial infarction (AMI). METHODS: Between November 2005 and January 2008, 6,781 patients who were not receiving an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jang Hoon, Bae, Myung Hwan, Yang, Dong Heon, Park, Hun Sik, Cho, Yongkeun, Lee, Won Kee, Jeong, Myung Ho, Kim, Young Jo, Cho, Myeong Chan, Kim, Chong Jin, Chae, Shung Chull
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773713/
https://www.ncbi.nlm.nih.gov/pubmed/26701233
http://dx.doi.org/10.3904/kjim.2014.268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773713/
https://www.ncbi.nlm.nih.gov/pubmed/26701233
http://dx.doi.org/10.3904/kjim.2014.268

Ejemplares similares